Researchers Identify Protein That can be Targeted to Treat Alzheimer's at Early Stage

Early accumulation of a small protein, known as amyloid beta, in the blood vessels of the brain can drive early cognitive impairment, a team of researchers has discovered. The findings by Stony Brook University researchers suggested that targeting early buildup of amyloid in brain blood vessels could be a potential treatment strategy in early stage disease. When amyloid accumulates and aggregates in the Alzheimer's disease process, amyloid deposits as ...

Read More